Patupilone - Hunan Dinuo PharmaceuticalAlternative Names: Epothilone B - Hunan Dinuo Pharmaceutical
Latest Information Update: 16 Jul 2016
At a glance
- Originator Hunan Dinuo Pharmaceutical
- Class Antineoplastics; Epothilones
- Mechanism of Action Mitosis inhibitors; Tubulin polymerisation promoters
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Cancer in China (IV)
- 06 Nov 2012 Phase-I clinical trials in Cancer in China (IV)